Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECISION: Celecoxib Safety in Arthritis
NCT00346216Phase 4Completed
- Sponsor
- Viatris
- Start
- Oct 2006
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 13
01
Overview
Phase 4, randomised, double-blind trial of celecoxib oral solution in osteoarthritis (OA) and rheumatoid arthritis (RA) (3 arms), sponsored by Viatris. Primary endpoint: Antiplatelet Trialists Collaboration Composite Endpoint at 42 months. Started Oct 2006; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00346216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00346216.